Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Yoshida

Showing results (131-140 of 337) with videos related to

Pageof 34
Sort By:
IEEE Transactions on Bio-Medical Engineering|June 8, 2007
Shape memory alloy microactuation of tf-lIFes: preliminary resultsSilvia Bossi, Arianna Menciassi, Klaus Peter Koch, et al.
Anticancer Research|February 7, 2016
Treatment Results of Radiotherapy Combined with Balloon-occluded Arterial Infusion Chemotherapy for Invasive Bladder CancerHiroto Yoshioka, Taiju Shimbo, Ken Yoshida, et al.
Modern Rheumatology|December 5, 2006
Two cases of adult Still's disease with abnormally high level of telomerase activity in peripheral blood mononuclear cellsDaitaro Kurosaka, Jun Yasuda, Isamu Kingetsu, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2002
Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrineTakashi Omura, Minoru Yoshiyama, Ken Yoshida, et al.
Molecular and Clinical Oncology|August 8, 2017
Effect of intratumoral abscess/necrosis on the outcome for head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife®Hideya Yamazaki, Mikio Ogita, Kengo Himei, et al.
Journal of Radiation Research|December 1, 2017
Radiotherapy for locally advanced resectable T3-T4 laryngeal cancer-does laryngeal preservation strategy compromise survival?Hideya Yamazaki, Gen Suzuki, Satoaki Nakamura, et al.
Anticancer Research|April 3, 2014
Comparison of common terminology criteria for adverse events v3.0 and radiation therapy oncology group toxicity score system after high-dose-rate interstitial brachytherapy as monotherapy for prostate cancerKen Yoshida, Hideya Yamazaki, Satoaki Nakamara, et al.
The Journal of Dermatology|November 19, 2016
Septic arthritis caused by Mycobacterium marinum infectionMiki Chiba, Koichi Yanaba, Aki Kohara, et al.
Anticancer Research|June 13, 2014
Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapyKen Yoshida, Hideya Yamazaki, Satoaki Nakamura, et al.
Journal of Radiation Research|March 18, 2016
Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancerHideya Yamazaki, Mikio Ogita, Kengo Himei, et al.
Pageof 34

Showing results (131-140 of 337) with videos related to

Sort By:
Pageof 34
IEEE Transactions on Bio-Medical Engineering|June 8, 2007
Shape memory alloy microactuation of tf-lIFes: preliminary resultsSilvia Bossi, Arianna Menciassi, Klaus Peter Koch, et al.
Anticancer Research|February 7, 2016
Treatment Results of Radiotherapy Combined with Balloon-occluded Arterial Infusion Chemotherapy for Invasive Bladder CancerHiroto Yoshioka, Taiju Shimbo, Ken Yoshida, et al.
Modern Rheumatology|December 5, 2006
Two cases of adult Still's disease with abnormally high level of telomerase activity in peripheral blood mononuclear cellsDaitaro Kurosaka, Jun Yasuda, Isamu Kingetsu, et al.
Hypertension (Dallas, Tex. : 1979)|January 19, 2002
Dominant negative mutant of c-Jun inhibits cardiomyocyte hypertrophy induced by endothelin 1 and phenylephrineTakashi Omura, Minoru Yoshiyama, Ken Yoshida, et al.
Molecular and Clinical Oncology|August 8, 2017
Effect of intratumoral abscess/necrosis on the outcome for head and neck cancer patients treated by hypofractionated stereotactic re-irradiation using CyberKnife®Hideya Yamazaki, Mikio Ogita, Kengo Himei, et al.
Journal of Radiation Research|December 1, 2017
Radiotherapy for locally advanced resectable T3-T4 laryngeal cancer-does laryngeal preservation strategy compromise survival?Hideya Yamazaki, Gen Suzuki, Satoaki Nakamura, et al.
Anticancer Research|April 3, 2014
Comparison of common terminology criteria for adverse events v3.0 and radiation therapy oncology group toxicity score system after high-dose-rate interstitial brachytherapy as monotherapy for prostate cancerKen Yoshida, Hideya Yamazaki, Satoaki Nakamara, et al.
The Journal of Dermatology|November 19, 2016
Septic arthritis caused by Mycobacterium marinum infectionMiki Chiba, Koichi Yanaba, Aki Kohara, et al.
Anticancer Research|June 13, 2014
Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapyKen Yoshida, Hideya Yamazaki, Satoaki Nakamura, et al.
Journal of Radiation Research|March 18, 2016
Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancerHideya Yamazaki, Mikio Ogita, Kengo Himei, et al.
Pageof 34